| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |